Trial Profile

A Pilot Study for Detection of PSMA-Low Castration Resistant and Neuroendocrine Prostate Cancer With 18F-fluciclovine PET/CT Imaging

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 05 Nov 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fluciclovine 18F (Primary)
Indications Neuroendocrine carcinoma; Prostate cancer
Focus Diagnostic use
Sponsors Blue Earth Diagnostics

Most Recent Events

29 Oct 2026 Planned primary completion date changed from 1 Sep 2026 to 1 Sep 2027.
25 Jun 2024 Status changed from not yet recruiting to recruiting.
09 Oct 2023 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com